ReviewEarly prediction of drug metabolism and toxicity: systems biology approach and modeling
Section snippets
In-silico prediction of drug metabolism and related toxicity – the current state of affairs
A major step in assessing the potential toxicity of a novel chemical entity is the prediction of entry and fate of the compound in human metabolism. There are two distinct sides to this problem. The first task is to predict nominal metabolic transformations of a molecule. The second is to understand which enzymes will actually be involved, predict relative importance of alternate reaction routes and finally, their interactions with endogenous metabolism.
Over the years several computational
QSAR modeling
Much of the work in QSAR modeling has been focused on potential interactions of small molecules with major classes of proteins such as drug metabolizing enzymes 10, 11, 12, transporters [13], channels [14] and receptors 15, 16. These models usually correlate physicochemical descriptors with measured properties such as compound–enzyme binding and substrate potential. In a series of recent reviews and publications, QSAR models for substrates of several major drug-metabolizing cytochromes have
High-throughput ‘new biology’ and toxicology
During the 1990s, a new set of methods were developed to greatly increase the amount of experimental data from one experiment. These methods include automated DNA sequencing, microarray analysis of gene expression and protein profiling. Although these techniques have a wide variety of applications, we will consider only those related to toxicology here.
System-level reconstruction of endogenous pathways
Systems biology was defined by its founders as the integration of experimental data generated by high-throughput platforms (genetic, transcriptomic, proteomic, metabonomic) to understand function through different levels of biomolecular organization [46]. In the narrowest sense, this term describes the computational systems and models that deal with the analysis of the vast experimental data accumulated during the past ten years of ‘new biology’. These systems have multiple applications in drug
Pathway databases
A handful of public and commercial efforts have systematically emphasized various aspects of general biochemistry, metabolism and cell signaling. The first tier of these projects is essentially reference databases. These resources provide access to data on individual enzymatic reactions and their parameters (BRENDA [47], EMP [48]), multi-step metabolic pathways (MPW [49], EcoCyc and HumanCyc [50]) or human-curated maps for entire functional blocks [KEGG [43] and Biocarta (http://www.biocarta.com
Pathway reconstruction platforms
This second class of resource provides an added functionality to pathway databases by reconstructing condition-specific pictures of relevant pathways. These reconstructions, dubbed metabolic reconstructions (MR), have been pioneered by Selkov and co-workers 50, 51. Metabolic blocks corresponding to the genetic component of the organism are connected into wire diagrams for each different bacterial species. For some better-studied bacterial species, such as Escherichia coli and Bacillus subtilis,
Next steps – predictive ADME/Tox in the systems biology era
The theoretical and experimental approaches described in this review address different aspects of assessing metabolism and toxicity of novel drug candidates. What is needed is a platform that integrates different types of in silico modeling with high-throughput molecular assays and that enables the reconstruction of a system-level picture of the behavior of a drug. We envision the next generation platforms for predictive ADME/Tox as integrated systems that can process different types of inputs
Concluding remarks
In summary, we believe that the data and methodologies exist to greatly improve ADME/Tox prediction of novel chemical compounds early in the drug discovery process. The integration of modeling, high-throughput and systems biology approaches will allow true breakthroughs in in silico ADME/Tox assessment.
References (59)
Predicting metabolic pathways by logic programming
J. Mol. Graph.
(1988)- et al.
Pharmacophore modeling of cytochromes P450
Adv. Drug Deliv. Rev.
(2002) Modeling of active transport systems
Adv. Drug Deliv. Rev.
(2002)Further evaluation of COMPACT, the molecular orbital approach for the prospective safety evaluation of chemicals
Mutat. Res.
(1998)Effects of propofol on functional activities of hepatic and extrahepatic conjugation enzyme systems
Br. J. Anaesth.
(2000)Genomic interrogation of mechanisms underlying cellular responses to toxicants. Toxicology
(2002)Identifying toxic mechanisms using DNA microarrays
Toxicology
(2002)- et al.
Proteomics: quantitative and physical mapping of cellular proteins
Trends Biotechnol.
(1999) The effects of peroxisome proliferators on protein abundance in mouse liver
Toxicol. Appl. Pharmacol.
(1996)Changes in the liver protein pattern of female Wistar rats treated with the hypoglycemic agent SDZ PGU 693
Life Sci.
(1998)